Recommended Contraceptive Regimen for Women with PCOS and Family History of VTE
In a woman with PCOS who has a first-degree relative with venous thromboembolism before age 60, progestin-only contraception (microdose or macrodose) or a levonorgestrel IUD should be prescribed as first-line contraception, avoiding combined estrogen-progestin contraceptives.
Primary Recommendation
A family history of thromboembolic events in a first-degree relative before age 60 is a relative contraindication to estrogen-progestin contraception 1. The presence of PCOS adds additional thrombotic risk, as women with PCOS have a baseline 1.5-fold increased risk of VTE even without oral contraceptives, which increases to 2-fold when combined oral contraceptives are added 2.
The first-line option for these women is microdose or macrodose progestin-based contraception 1.
Specific Contraceptive Options
Preferred Methods (No Increased VTE Risk):
- Progestin-only pills containing desogestrel 75 mcg or levonorgestrel 30 mcg - these show no significant increase in VTE risk (OR: 1.45,95% CI: 0.92-2.26) 1
- Levonorgestrel IUD - no excess VTE risk noted, with relative risk of 0.61 (95% CI: 0.24-1.53) 1, 3, 1
- Copper IUD - non-hormonal option with no thrombotic risk 3
Methods to Avoid:
- Combined estrogen-progestin contraceptives (pills, patches, vaginal rings) - formally contraindicated given family history 1
- Depot medroxyprogesterone acetate (DMPA) - shows increased VTE risk (RR 2.67,95% CI: 1.29-5.53) similar to combined oral contraceptives 3
- Transdermal patches and vaginal rings - increase thromboembolism risk by 3-4 fold 1
Additional Considerations for PCOS
While combined oral contraceptives are typically first-line for PCOS management (addressing irregular menses, androgen excess, and endometrial protection) 4, 5, the family history of early VTE shifts the risk-benefit balance decisively toward progestin-only methods.
The levonorgestrel IUD offers particular advantages in PCOS patients:
- Provides effective contraception when other methods are contraindicated
- Regulates abnormal uterine bleeding
- Protects against endometrial hyperplasia and cancer risk associated with chronic anovulation 4
- May be preferred over oral megestrol acetate for endometrial protection in obese PCOS patients 4
Thrombophilia Screening
Screening for thrombophilia should be performed given the first-degree family history before age 60 1. Testing should include:
- Prothrombin time (PT)
- Activated partial thromboplastin time (aPTT)
- Antithrombin levels
- Protein C and Protein S levels
- Factor V Leiden
- Prothrombin (FII) 20210A mutation
If documented thrombophilia is found, combined estrogen-progestin contraception becomes formally contraindicated (not just relatively contraindicated), and progestin-only methods remain the appropriate choice 1.
Common Pitfalls to Avoid
- Do not prescribe combined oral contraceptives despite their benefits for PCOS symptoms - the thrombotic risk outweighs the benefits in this clinical scenario
- Do not use DMPA - despite being progestin-only, it carries similar VTE risk to combined contraceptives 3
- Do not skip thrombophilia screening - this is specifically indicated with first-degree family history before age 60 1
- Do not assume all progestin-only methods are equivalent - levonorgestrel and desogestrel formulations have the best safety data, while DMPA does not 1, 3